Advisors Asset Management’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-280
| Closed | -$62.9K | – | 1526 |
|
|
2024
Q3 | $62.9K | Sell |
280
-214
| -43% | -$38.5K | ﹤0.01% | 1286 |
|
|
2024
Q2 | $70.5K | Sell |
494
-149
| -23% | -$23K | ﹤0.01% | 1246 |
|
|
2024
Q1 | $101K | Sell |
643
-214
| -25% | -$34.5K | ﹤0.01% | 1218 |
|
|
2023
Q4 | $155K | Sell |
857
-205
| -19% | -$37.1K | ﹤0.01% | 1150 |
|
|
2023
Q3 | $191K | Buy |
1,062
+183
| +21% | +$36.2K | ﹤0.01% | 1121 |
|
|
2023
Q2 | $157K | Buy |
879
+18
| +2% | +$4.14K | ﹤0.01% | 1159 |
|
|
2023
Q1 | $186K | Sell |
861
-30
| -3% | -$7.2K | ﹤0.01% | 1131 |
|
|
2022
Q4 | $196K | Buy |
891
+109
| +14% | +$20K | ﹤0.01% | 1128 |
|
|
2022
Q3 | $105K | Sell |
782
-491
| -39% | -$84.3K | ﹤0.01% | 1254 |
|
|
2022
Q2 | $206K | Buy |
1,273
+29
| +2% | +$4.53K | ﹤0.01% | 1158 |
|
|
2022
Q1 | $235K | Buy |
1,244
+262
| +27% | +$55.7K | ﹤0.01% | 1195 |
|
|
2021
Q4 | $266K | Buy |
982
+132
| +16% | +$44.6K | ﹤0.01% | 1168 |
|
|
2021
Q3 | $309K | Sell |
850
-205
| -19% | -$67K | ﹤0.01% | 1141 |
|
|
2021
Q2 | $362K | Sell |
1,055
-657
| -38% | -$218K | 0.01% | 1090 |
|
|
2021
Q1 | $596K | Sell |
1,712
-175
| -9% | -$57.9K | 0.01% | 976 |
|
|
2020
Q4 | $488K | Buy |
1,887
+370
| +24% | +$102K | 0.01% | 975 |
|
|
2020
Q3 | $435K | Buy |
1,517
+217
| +17% | +$51K | 0.01% | 954 |
|
|
2020
Q2 | $245K | Buy |
1,300
+19
| +1% | +$3.09K | ﹤0.01% | 1116 |
|
|
2020
Q1 | $158K | Buy |
1,281
+346
| +37% | +$54.1K | ﹤0.01% | 1151 |
|
|
2019
Q4 | $155K | Buy |
935
+653
| +232% | +$108K | ﹤0.01% | 1258 |
|
|
2019
Q3 | $35K | Buy |
282
+82
| +41% | +$10.9K | ﹤0.01% | 1436 |
|
|
2019
Q2 | $25K | Buy |
200
+80
| +67% | +$10.2K | ﹤0.01% | 1455 |
|
|
2019
Q1 | $16K | Buy |
+120
| New | +$16.2K | ﹤0.01% | 1723 |
|
Other funds holding ONC
BBA
HA
